FDA CDER Acknowledgment Letter to Annora Pharma
Summary
FDA CDER issued an acknowledgment letter to Annora Pharma Private Limited dated April 24, 2026. The acknowledgment appears in connection with docket FDA-2026-P-4574, indicating receipt of a pre-submission package or IND submission for review. No substantive regulatory determinations or compliance obligations are contained in this acknowledgment document.
About this source
Every FDA document on regulations.gov, the federal rulemaking portal. This is where the agency posts variances, advisory committee meeting notices, draft guidance for comment, citizen petition responses, and procedural rules that do not get a separate Federal Register slot. Around 240 a month. FDA's heavy regulations.gov use means tracking only the Federal Register misses a meaningful chunk of what the agency does day-to-day. Watch this if you manufacture devices, submit IND or NDA applications, run a lab, or advise sponsors on FDA process. GovPing publishes each posting with the docket, document type, division (CDER, CDRH, CFSAN), and comment window where one applies.
What changed
FDA CDER issued an acknowledgment letter to Annora Pharma confirming receipt of a submission associated with docket FDA-2026-P-4574. The acknowledgment letter represents a procedural administrative step, confirming that the agency has received and is processing Annora Pharma's submission. No substantive review findings, approval decisions, or compliance requirements are contained in this acknowledgment. Affected parties should await further substantive correspondence from FDA CDER regarding their submission status.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Content
There are no documents available to view or download
Attachments 1
Acknowledgment Letter from FDA CDER to Annora Pharma Private Limited
More Information
- Author(s) CDER
Download
Parties
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA CDER.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.